Investigating the impact of CircRNAs on cancer progression and drug resistance

The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance.

Japan approves GSK’s Nucala for rhinosinusitis with nasal polyps

GSK’s asset is specifically for CRSwNP patients whose condition is inadequately controlled with standard therapy. Credit: OleksSH/Shutterstock. Japan’s Ministry of Health, Labour and Welfare (MHLW)

August 29, 2024

MedPage Today Readers Backed Harris, Survey Shows

While former President Donald Trump won the 2024 election, Democratic presidential candidate and Vice President Kamala Harris was the clear choice among MedPage Today readers.

November 7, 2024

Q&A: Vertex’s pain research chief on moving beyond opioids, AI and how pharma acquisitions thrive or fail

SAN DIEGO — For savvy dealmaking, Vertex’s 2001 acquisition of Aurora Biosciences is near the top of the list. Vertex bought the San Diego biotech

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.